Article
Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapy
2022-06-26
Abstract excerpt
Unleashing anti-tumor T cell activity by checkpoint inhibition is effective in many cancer patients but clinical response rates remain limited. Myeloid derived suppressor cells erode antitumor lymphocyte numbers and function, and correlate with resistance to checkpoint inhibitors. By screening small molecule libraries, we identified JAK inhibitors’ ability to rescue T cell function. Despite its documented immune s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ff3b2570-0eda-574f-b060-1c318883662c
- DOI
- 10.1101/2022.06.24.497435
